Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

(2013) Kirsten de Groot   ANNALS OF INTERNAL MEDICINE

Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis

(2011) Michael Walsh et al.   ARTHRITIS AND RHEUMATISM

The Five-Factor Score Revisited

(2011) Loïc Guillevin et al.   MEDICINE

A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

(2011) Ravi Suppiah et al.   ARTHRITIS CARE & RESEARCH

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis

(2009) M. A. Little et al.   ANNALS OF THE RHEUMATIC DISEASES

Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis

(2009) Mikkel Faurschou et al.   ARTHRITIS AND RHEUMATISM

Development of comprehensive disease assessment in systemic vasculitis

(2006) O Flossmann et al.   POSTGRADUATE MEDICAL JOURNAL